CellWell record HH-144846
Potassium-enriched salt for patients with hypertension: a Hypertension Australia and National Hypertension Taskforce of Australia Position Statement
Xiaoyue Xu; Mary-Anne Land; Sharon James; Clara Chow; Jun Yang; James E Sharman; Jonathan Golledge; Breonny Robson; Audrey Lee; Charlotte Hespe; Chris Campbell; Lisa Murphy; Geoffrey C Cloud; Anthony Rodgers; Jessica Seeto; Nigel P Stocks; Tim Usherwood; Mark R Nelson; Markus P Schlaich; Bruce Neal; Aletta E Schutte
2026
In plain language
A position statement from Hypertension Australia recommends that patients with hypertension switch regular salt for potassium-enriched salt (about 75% sodium chloride, 25% potassium chloride) to lower blood pressure, unless at hyperkalemia risk.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-144846
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.